| abstract |
The present invention provides a pharmaceutical composition comprising, as an active ingredient, 10 mg to about 100 g of KRED and/or long-acting alcohol dehydrogenase and a pharmaceutically acceptable carrier. Furthermore, provided herein are methods of reducing blood alcohol levels, methods of preventing symptoms or risks caused by alcohol consumption, and methods of treating subjects suffering from alcoholism by administering the pharmaceutical compositions of the present invention. |